Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -2.51 Million USD | -487.16% |
| 2023 | -427.81 Thousand USD | 63.17% |
| 2022 | -526.56 Thousand USD | -53.08% |
| 2021 | 50.17 Thousand USD | 42.11% |
| 2020 | -1.31 Million USD | -193.97% |
| 2019 | -573.98 Thousand USD | -38.73% |
| 2018 | -321.4 Thousand USD | 66.87% |
| 2017 | -968.73 Thousand USD | 8.66% |
| 2016 | -1 Million USD | 17.08% |
| 2015 | -1.21 Million USD | -11.04% |
| 2014 | -1.15 Million USD | 5.12% |
| 2013 | -1.76 Million USD | 4.33% |
| 2012 | 1.01 Million USD | -36.07% |
| 2011 | -934.09 Thousand USD | -188.12% |
| 2010 | -324.2 Thousand USD | 31.78% |
| 2009 | -475.22 Thousand USD | 71.57% |
| 2008 | -1.46 Million USD | 40.6% |
| 2007 | -2.81 Million USD | -20.1% |
| 2006 | -2.14 Million USD | 29.35% |
| 2005 | -3.44 Million USD | 1.16% |
| 2004 | -3.4 Million USD | -32.94% |
| 2003 | -2.72 Million USD | 50.56% |
| 2002 | -9.55 Million USD | -35.12% |
| 2001 | -3.77 Million USD | -95.9% |
| 2000 | -1.92 Million USD | -48.39% |
| 1999 | -1.3 Million USD | 31.58% |
| 1998 | -1.7 Million USD | -1800.0% |
| 1997 | -100 Thousand USD | -114.29% |
| 1996 | 700 Thousand USD | -12.5% |
| 1995 | 900 Thousand USD | 700.0% |
| 1994 | 100 Thousand USD | 107.14% |
| 1993 | -1.3 Million USD | -1300.0% |
| 1992 | - USD | -133.33% |
| 1991 | 300 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -651.46 Thousand USD | -84.17% |
| 2024 Q4 | -1.3 Million USD | -530.72% |
| 2024 Q1 | -353.72 Thousand USD | -3446.54% |
| 2024 Q3 | -206.2 Thousand USD | 68.35% |
| 2023 Q4 | -561.26 Thousand USD | -27.4% |
| 2023 Q3 | -440.55 Thousand USD | -158.81% |
| 2023 Q2 | 749.15 Thousand USD | 1991.33% |
| 2023 Q1 | 35.82 Thousand USD | 109.47% |
| 2023 FY | - USD | 63.17% |
| 2022 Q4 | -378.16 Thousand USD | -1122.57% |
| 2022 FY | - USD | -53.08% |
| 2022 Q1 | -357.49 Thousand USD | 9.73% |
| 2022 Q2 | -394.95 Thousand USD | -10.48% |
| 2022 Q3 | -30.93 Thousand USD | 92.17% |
| 2021 Q2 | -177.08 Thousand USD | -582.7% |
| 2021 Q4 | -396.02 Thousand USD | -78.09% |
| 2021 FY | - USD | 42.11% |
| 2021 Q1 | 36.68 Thousand USD | 112.95% |
| 2021 Q3 | -222.36 Thousand USD | -25.57% |
| 2020 Q3 | -435.91 Thousand USD | 17.53% |
| 2020 Q1 | -62.96 Thousand USD | 32.23% |
| 2020 FY | - USD | -193.97% |
| 2020 Q4 | -283.28 Thousand USD | 35.01% |
| 2020 Q2 | -528.59 Thousand USD | -739.55% |
| 2019 Q1 | -291.82 Thousand USD | -1325.89% |
| 2019 Q2 | -116.7 Thousand USD | 60.01% |
| 2019 Q4 | -92.9 Thousand USD | -28.04% |
| 2019 FY | - USD | -38.73% |
| 2019 Q3 | -72.55 Thousand USD | 37.82% |
| 2018 Q4 | 23.8 Thousand USD | 108.72% |
| 2018 FY | - USD | 66.87% |
| 2018 Q1 | -19.51 Thousand USD | 91.39% |
| 2018 Q2 | -52.79 Thousand USD | -170.45% |
| 2018 Q3 | -272.89 Thousand USD | -416.95% |
| 2017 Q3 | -153.88 Thousand USD | 49.73% |
| 2017 FY | - USD | 8.66% |
| 2017 Q1 | -286.41 Thousand USD | -95.09% |
| 2017 Q2 | -306.09 Thousand USD | -6.87% |
| 2017 Q4 | -226.63 Thousand USD | -47.28% |
| 2016 FY | - USD | 17.08% |
| 2016 Q3 | -244.65 Thousand USD | 21.03% |
| 2016 Q2 | -309.8 Thousand USD | 18.36% |
| 2016 Q1 | -379.48 Thousand USD | -3.61% |
| 2016 Q4 | -146.81 Thousand USD | 39.99% |
| 2015 Q3 | -271.63 Thousand USD | 15.13% |
| 2015 FY | - USD | -11.04% |
| 2015 Q2 | -320.07 Thousand USD | 0.94% |
| 2015 Q1 | -323.11 Thousand USD | -1.19% |
| 2015 Q4 | -366.27 Thousand USD | -34.84% |
| 2014 Q1 | -201.85 Thousand USD | -20.94% |
| 2014 Q3 | -383.47 Thousand USD | -53.95% |
| 2014 FY | - USD | 5.12% |
| 2014 Q2 | -249.09 Thousand USD | -23.4% |
| 2014 Q4 | -319.31 Thousand USD | 16.73% |
| 2013 Q1 | -355.63 Thousand USD | -117.16% |
| 2013 Q4 | -166.91 Thousand USD | 51.7% |
| 2013 Q2 | 201.19 Thousand USD | 156.57% |
| 2013 Q3 | -345.54 Thousand USD | -271.74% |
| 2013 FY | - USD | 4.33% |
| 2012 FY | - USD | -36.07% |
| 2012 Q3 | -500.36 Thousand USD | -62.77% |
| 2012 Q2 | -307.39 Thousand USD | 87.88% |
| 2012 Q1 | -2.53 Million USD | -933.33% |
| 2012 Q4 | 2.07 Million USD | 514.17% |
| 2011 FY | - USD | -188.12% |
| 2011 Q1 | -128.33 Thousand USD | -539.19% |
| 2011 Q2 | -337.14 Thousand USD | -162.72% |
| 2011 Q3 | -287.31 Thousand USD | 14.78% |
| 2011 Q4 | -245.38 Thousand USD | 14.59% |
| 2010 Q4 | 29.22 Thousand USD | 159.97% |
| 2010 Q2 | -218.59 Thousand USD | -153.88% |
| 2010 Q3 | -48.72 Thousand USD | 77.71% |
| 2010 Q1 | -86.1 Thousand USD | -5.73% |
| 2010 FY | - USD | 31.78% |
| 2009 Q1 | -226.38 Thousand USD | 23.98% |
| 2009 FY | - USD | 71.57% |
| 2009 Q2 | -22.23 Thousand USD | 90.18% |
| 2009 Q3 | -145.16 Thousand USD | -552.8% |
| 2009 Q4 | -81.43 Thousand USD | 43.9% |
| 2008 FY | - USD | 40.6% |
| 2008 Q2 | -617.6 Thousand USD | -39.16% |
| 2008 Q1 | -443.8 Thousand USD | 21.68% |
| 2008 Q4 | -297.8 Thousand USD | 4.72% |
| 2008 Q3 | -312.55 Thousand USD | 49.39% |
| 2007 Q3 | 3.37 Million USD | 565.18% |
| 2007 FY | - USD | -20.1% |
| 2007 Q4 | -566.68 Thousand USD | -116.8% |
| 2007 Q2 | -725.21 Thousand USD | -4.95% |
| 2007 Q1 | -690.99 Thousand USD | -15.81% |
| 2006 Q2 | -600.64 Thousand USD | 13.37% |
| 2006 Q1 | -693.33 Thousand USD | 28.01% |
| 2006 FY | - USD | 29.35% |
| 2006 Q4 | -596.66 Thousand USD | -31.76% |
| 2006 Q3 | -452.84 Thousand USD | 24.61% |
| 2005 Q2 | -777.1 Thousand USD | 13.31% |
| 2005 Q4 | -963.15 Thousand USD | -25.1% |
| 2005 Q3 | -769.9 Thousand USD | 0.93% |
| 2005 Q1 | -896.38 Thousand USD | 4.75% |
| 2005 FY | - USD | 1.16% |
| 2004 Q1 | -593.93 Thousand USD | 33.97% |
| 2004 Q4 | -941.05 Thousand USD | -10.47% |
| 2004 Q3 | -851.82 Thousand USD | 12.1% |
| 2004 Q2 | -969.13 Thousand USD | -63.17% |
| 2004 FY | - USD | -32.94% |
| 2003 Q1 | -737.07 Thousand USD | 85.27% |
| 2003 Q4 | -1.02 Million USD | -145.59% |
| 2003 Q3 | -365.39 Thousand USD | 30.51% |
| 2003 Q2 | -609.38 Thousand USD | 27.96% |
| 2003 FY | - USD | 50.56% |
| 2002 FY | - USD | -35.12% |
| 2002 Q2 | -1.22 Million USD | 76.98% |
| 2002 Q1 | -5.85 Million USD | -77.01% |
| 2002 Q3 | -1.01 Million USD | -83.61% |
| 2002 Q4 | -5.3 Million USD | -387.92% |
| 2001 Q1 | -493.86 Thousand USD | -21.39% |
| 2001 FY | - USD | -95.9% |
| 2001 Q3 | -1.06 Million USD | -23.85% |
| 2001 Q4 | -1.36 Million USD | -27.85% |
| 2001 Q2 | -859.57 Thousand USD | -74.05% |
| 2000 FY | - USD | -48.39% |
| 2000 Q4 | -406.83 Thousand USD | 28.55% |
| 2000 Q3 | -569.37 Thousand USD | 5.1% |
| 2000 Q2 | -600 Thousand USD | -50.0% |
| 2000 Q1 | -383.11 Thousand USD | 0.0% |
| 1999 FY | - USD | 31.58% |
| 1999 Q1 | -300 Thousand USD | 50.0% |
| 1999 Q2 | -200 Thousand USD | 33.33% |
| 1999 Q3 | -309.15 Thousand USD | -50.0% |
| 1999 Q4 | -400 Thousand USD | -33.33% |
| 1998 FY | - USD | -1800.0% |
| 1998 Q4 | -600 Thousand USD | -20.0% |
| 1998 Q1 | -200 Thousand USD | 50.0% |
| 1998 Q2 | -500 Thousand USD | -150.0% |
| 1998 Q3 | -400 Thousand USD | 0.0% |
| 1997 Q3 | -300 Thousand USD | -250.0% |
| 1997 Q1 | 300 Thousand USD | 200.0% |
| 1997 Q4 | -400 Thousand USD | -33.33% |
| 1997 FY | - USD | -114.29% |
| 1997 Q2 | 200 Thousand USD | -33.33% |
| 1996 FY | - USD | -12.5% |
| 1996 Q2 | 100 Thousand USD | -66.67% |
| 1996 Q1 | 300 Thousand USD | -25.0% |
| 1996 Q4 | 100 Thousand USD | -50.0% |
| 1996 Q3 | 200 Thousand USD | 100.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| 1995 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q1 | - USD | 100.0% |
| 1995 FY | - USD | 700.0% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q1 | -100 Thousand USD | 87.5% |
| 1994 Q2 | - USD | 100.0% |
| 1994 FY | - USD | 107.14% |
| 1994 Q4 | -100 Thousand USD | -200.0% |
| 1993 Q1 | -200 Thousand USD | 95.65% |
| 1993 Q4 | -800 Thousand USD | -700.0% |
| 1993 Q3 | -100 Thousand USD | 50.0% |
| 1993 FY | - USD | -1300.0% |
| 1993 Q2 | -200 Thousand USD | 0.0% |
| 1992 FY | - USD | -133.33% |
| 1992 Q2 | 1.5 Million USD | -6.25% |
| 1992 Q1 | 1.6 Million USD | 151.61% |
| 1992 Q4 | -4.6 Million USD | -428.57% |
| 1992 Q3 | 1.4 Million USD | -6.67% |
| 1991 Q1 | 1.1 Million USD | 0.0% |
| 1991 Q3 | 1.1 Million USD | 0.0% |
| 1991 Q4 | -3.1 Million USD | -381.82% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | 1.1 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 94.495% |
| AngioDynamics, Inc. | -14.29 Million USD | 82.424% |
| AtriCure, Inc. | -8.1 Million USD | 69.023% |
| Avinger, Inc. | -16.34 Million USD | 84.633% |
| Azenta, Inc. | 55.15 Million USD | 104.555% |
| BioLife Solutions, Inc. | -45.23 Million USD | 94.447% |
| The Cooper Companies, Inc. | 882.8 Million USD | 100.285% |
| Daxor Corporation | 329.74 Thousand USD | 861.797% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 80.967% |
| Femasys Inc. | -13.16 Million USD | 80.926% |
| GlucoTrack, Inc. | -7.09 Million USD | 64.576% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 126.461% |
| Hologic, Inc. | 1.29 Billion USD | 100.194% |
| ICU Medical, Inc. | 307.69 Million USD | 100.816% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.105% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 73.276% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 105.127% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 61.796% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 61.796% |
| Masimo Corporation | 236.7 Million USD | 101.061% |
| Microbot Medical Inc. | -10.63 Million USD | 76.378% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 115.928% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 101.085% |
| Nephros, Inc. | -1.37 Million USD | -82.157% |
| NovoCure Limited | -175.86 Million USD | 98.572% |
| NEXGEL, Inc. | -2.73 Million USD | 7.987% |
| NEXGEL, Inc. | -2.73 Million USD | 7.987% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 97.096% |
| OraSure Technologies, Inc. | 76.15 Million USD | 103.298% |
| Pro-Dex, Inc. | 8.33 Million USD | 130.145% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 94.071% |
| Predictive Oncology Inc. | -13.18 Million USD | 80.944% |
| QuidelOrtho Corporation | 545.6 Million USD | 100.46% |
| Repligen Corporation | 124.29 Million USD | 102.021% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -768.896% |
| STAAR Surgical Company | 33.22 Million USD | 107.561% |
| Sharps Technology, Inc. | -8.98 Million USD | 72.028% |
| Utah Medical Products, Inc. | 24.8 Million USD | 110.127% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 101.083% |
| Jin Medical International Ltd. | 3.44 Million USD | 172.961% |